iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · Real-Time Price · USD
2.190
-0.040 (-1.79%)
At close: Nov 20, 2024, 4:00 PM
2.280
+0.090 (4.11%)
After-hours: Nov 20, 2024, 7:26 PM EST
iBio, Inc. Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for iBio, Inc. stock have an average target of 4.30, with a low estimate of 3.60 and a high estimate of 5.00. The average target predicts an increase of 96.35% from the current stock price of 2.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 22, 2024.
Analyst Ratings
The average analyst rating for iBio, Inc. stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Brookline Capital | Brookline Capital | Strong Buy Initiates $3.6 | Strong Buy | Initiates | $3.6 | +64.38% | Jul 22, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +128.31% | Jun 3, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +128.31% | May 28, 2024 |
JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 16, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $1,250 → $85 | Buy → Hold | Downgrades | $1,250 → $85 | +3,781.28% | Oct 7, 2022 |
Financial Forecast
Revenue This Year
n/a
from 225.00K
Revenue Next Year
n/a
EPS This Year
-1.81
from -6.50
EPS Next Year
-1.67
from -1.81
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 8.4M | ||
Avg | n/a | n/a | 8.2M | ||
Low | n/a | n/a | 7.8M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.61 | -1.29 | -0.76 | ||
Avg | -1.81 | -1.67 | -0.73 | ||
Low | -1.98 | -2.01 | -0.71 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.